{"id":371,"date":"2026-01-30T10:00:00","date_gmt":"2026-01-30T01:00:00","guid":{"rendered":"https:\/\/engitissuedesign.com\/?p=371"},"modified":"2026-09-28T15:33:53","modified_gmt":"2026-09-28T06:33:53","slug":"kapitalforhoyelsen-bringer-aksjekapitalen-over-100-millioner-yen-kapital-pa-111-351-300-yen","status":"publish","type":"post","link":"https:\/\/engitissuedesign.com\/nb\/kapitalforhoyelsen-bringer-aksjekapitalen-over-100-millioner-yen-kapital-pa-111-351-300-yen\/","title":{"rendered":"Kapitalforh\u00f8yelsen bringer aksjekapitalen over 100 millioner yen (kapital p\u00e5 111\u202f351\u202f300 yen)"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Vi kunngj\u00f8r at EngiTissue Design Co., Ltd. den 30. januar 2026 gjennomf\u00f8rte en kapitalforh\u00f8yelse og \u00f8kte aksjekapitalen til 111\u202f351\u202f300 yen. Med dette har selskapets aksjekapital passert 100 millioner yen.<\/p>\n<ul class=\"wp-block-list\"><li>Ikrafttredelsesdato: 30. januar 2026<\/li><li>Aksjekapital etter forh\u00f8yelsen: 111\u202f351\u202f300 yen<\/li><li>Totalt antall utstedte aksjer etter forh\u00f8yelsen: 1\u202f214 aksjer<\/li><\/ul>\n<p class=\"wp-block-paragraph\">Midlene som er hentet inn gjennom denne kapitalforh\u00f8yelsen, vil bli brukt til \u00e5 akselerere v\u00e5r forskning og utvikling og til \u00e5 utvide virksomheten. Vi takker for din fortsatte st\u00f8tte.<\/p>","protected":false},"excerpt":{"rendered":"<p>Vi kunngj\u00f8r at EngiTissue Design Co., Ltd. den 30. januar 2026 gjennomf\u00f8rte en kapitalforh\u00f8yelse og \u00f8kte aksjekapitalen til 111\u202f351\u202f300 yen. Med dette har selskapets aksjekapital passert 100 millioner yen. Ikrafttredelsesdato: 30. januar 2026 Aksjekapital etter forh\u00f8yelsen: 111\u202f351\u202f300 yen Totalt antall utstedte aksjer etter forh\u00f8yelsen: 1\u202f214 aksjer Midlene som er hentet inn gjennom denne kapitalforh\u00f8yelsen, vil [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":597,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[100],"tags":[],"class_list":["post-371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ir-og-kapital"],"_links":{"self":[{"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/posts\/371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/comments?post=371"}],"version-history":[{"count":1,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/posts\/371\/revisions"}],"predecessor-version":[{"id":372,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/posts\/371\/revisions\/372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/media\/597"}],"wp:attachment":[{"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/media?parent=371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/categories?post=371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/engitissuedesign.com\/nb\/wp-json\/wp\/v2\/tags?post=371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}